TH-302 is selective hypoxia-activated prodrug targeting hypoxic regions of solid tumors with IC50 of 19 nM, demonstrates 270-fold enhanced cytotoxicity under hypoxia versus their potency under aerobic conditions, stable to cytochrome P450 metabolism.

>98%

Store at -20℃ for one year（Powder）；Store at 2-4℃ for two weeks；Store at -20℃ for six months after dissolution.

TH 302; TH302

Powder

DMSO 90 mg/mL (200.42 mM)

Ethanol 90 mg/mL (200.42 mM)

Water 10 mg/mL warmed (22.26 mM)